Ameritas Investment Partners’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,012
| Closed | -$28K | – | 3129 |
|
|
2020
Q3 | $28K | Hold |
3,012
| – | – | ﹤0.01% | 2205 |
|
|
2020
Q2 | $23K | Hold |
3,012
| – | – | ﹤0.01% | 2305 |
|
|
2020
Q1 | $19K | Hold |
3,012
| – | – | ﹤0.01% | 2223 |
|
|
2019
Q4 | $37K | Hold |
3,012
| – | – | ﹤0.01% | 2088 |
|
|
2019
Q3 | $35K | Hold |
3,012
| – | – | ﹤0.01% | 2096 |
|
|
2019
Q2 | $30K | Hold |
3,012
| – | – | ﹤0.01% | 2213 |
|
|
2019
Q1 | $39K | Hold |
3,012
| – | – | ﹤0.01% | 2035 |
|
|
2018
Q4 | $46K | Hold |
3,012
| – | – | ﹤0.01% | 1869 |
|
|
2018
Q3 | $60K | Hold |
3,012
| – | – | ﹤0.01% | 1891 |
|
|
2018
Q2 | $59K | Hold |
3,012
| – | – | ﹤0.01% | 1886 |
|
|
2018
Q1 | $61K | Sell |
3,012
-1,000
| -25% | -$16.9K | ﹤0.01% | 1809 |
|
|
2017
Q4 | $60K | Hold |
4,012
| – | – | ﹤0.01% | 1831 |
|
|
2017
Q3 | $68K | Hold |
4,012
| – | – | ﹤0.01% | 1692 |
|
|
2017
Q2 | $73K | Hold |
4,012
| – | – | ﹤0.01% | 1660 |
|
|
2017
Q1 | $90K | Buy |
4,012
+3,012
| +301% | +$72.1K | ﹤0.01% | 1488 |
|
|
2016
Q4 | $34K | Hold |
1,000
| – | – | ﹤0.01% | 1138 |
|
|
2016
Q3 | $24K | Hold |
1,000
| – | – | ﹤0.01% | 1150 |
|
|
2016
Q2 | $23K | Hold |
1,000
| – | – | ﹤0.01% | 1086 |
|
|
2016
Q1 | $23K | Hold |
1,000
| – | – | ﹤0.01% | 1082 |
|
|
2015
Q4 | $30K | Buy |
+1,000
| New | +$32.3K | ﹤0.01% | 1056 |
|
Ameritas Investment Partners's AMAG Position: Q4 2020 in Review
Ameritas Investment Partners sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 3,012 shares — an estimated $28K sold.
Ameritas Investment Partners first reported a position in AMAG in Q4 2015 and held it in 20 quarters. The position peaked at $90K in Q1 2017. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Ameritas Investment Partners reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Ameritas Investment Partners sold 3,012 AMAG Pharmaceuticals shares in Q4 2020, an estimated $28K.
- Ameritas Investment Partners first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 20 quarters.
- Ameritas Investment Partners's AMAG Pharmaceuticals position peaked at $90K in Q1 2017.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Ameritas Investment Partners's 13F filing for Q4 2020, filed 12 Feb 2021.